Top Buy
| Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Brainstorm Cell | 1 | 0 | 0 | 0 | €0.36 | - | - |
| Catalyst Pharmaceutical Partners Inc | 14 | 0 | 3 | 0 | €14.05 | €24.13 | 71.767% |
| Celldex Therapeutics | 15 | 1 | 4 | 0 | €34.60 | €58.01 | 67.661% |
| Chromadex Corp | 11 | 1 | 1 | 0 | €2.50 | €5.55 | 122.144% |
| Codexis Inc. | 7 | 2 | 2 | 0 | €2.89 | €8.36 | 189.508% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 0 | 0 | €42.20 | €50.00 | 18.483% |
| Corcept Therapeutics Inc. | 14 | 0 | 3 | 0 | €29.97 | €37.08 | 23.717% |
| Corvus Pharmaceuticals Inc | 5 | 1 | 0 | 0 | €1.61 | €6.45 | 299.789% |
| Cytokinetics Inc. | 34 | 1 | 4 | 0 | €48.40 | €83.21 | 71.911% |
| Deciphera Pharmaceuticals | 6 | 0 | 0 | 0 | €23.80 | €24.97 | 4.929% |
| Dynavax Technologies Corp | 3 | 0 | 1 | 0 | €10.33 | €27.02 | 161.660% |
| Eledon Pharmaceuticals Inc. | 6 | 0 | 1 | 0 | €2.32 | €12.21 | 426.332% |
| Eli Lilly Corp. | 66 | 0 | 19 | 0 | €846.00 | €883.50 | 4.433% |
| Esperion Therapeutis.Inc. | 17 | 1 | 3 | 1 | €2.06 | €9.27 | 350.355% |
| Exact Sciences | 16 | 0 | 3 | 0 | €39.44 | €78.89 | 100.055% |
| Exelixis Inc. | 18 | 0 | 0 | 0 | €20.95 | €26.01 | 24.136% |
| EyePoint Pharmaceuticals Inc. | 22 | 1 | 4 | 0 | €8.12 | €27.83 | 242.831% |
| G1 Therapeutics | 21 | 5 | 5 | 4 | €2.12 | €8.39 | 295.745% |
| Geron Corp. | 16 | 0 | 4 | 0 | €3.96 | €5.56 | 40.541% |
| Gilead Sciences Inc | 15 | 1 | 4 | 0 | €64.05 | €79.54 | 24.189% |
| Halozyme Therapeutics Inc. | 20 | 0 | 5 | 0 | €48.90 | €52.75 | 7.869% |
| Heron Therapeutics Inc. | 12 | 1 | 1 | 0 | €3.18 | €4.60 | 44.595% |
| ImmunityBio Inc. | 2 | 0 | 0 | 0 | €5.90 | €10.00 | 69.607% |